drugset

drugset / Trial / NCT00988533

A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age

NCT00988533 ↗

Phase 1 Completed 30 enrolled Topaz Pharmaceuticals Inc

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the bioavailability of 0.5% ivermectin cream in a pediatric population aged 6 months to 3 years.

Timeline

Start: 2009-09
Primary completion: 2009-11
Completion: 2009-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ivermectin	Small molecule	0.5 %	Topical

Indications